1.ERp44 C160S/C212S mutants regulate IP3R1 channel activity.
Congyan PAN ; Ji ZHENG ; Yanyun WU ; Yingxiao CHEN ; Likun WANG ; Zhansong ZHOU ; Wenxuan YIN ; Guangju JI
Protein & Cell 2011;2(12):990-996
Previous studies have indicated that ERp44 inhibits inositol 1,4,5-trisphosphate (IP(3))-induced Ca(2+) release (IICR) via IP(3)R(1), but the mechanism remains largely unexplored. Using extracellular ATP to induce intracellular calcium transient as an IICR model, Ca(2+) image, pull down assay, and Western blotting experiments were carried out in the present study. We found that extracellular ATP induced calcium transient via IP(3)Rs (IICR) and the IICR were markedly decreased in ERp44 overexpressed Hela cells. The inhibitory effect of C160S/C212S but not C29S/T396A/ΔT(331-377) mutants of ERp44 on IICR were significantly decreased compared with ERp44. However, the binding capacity of ERp44 to L3V domain of IP(3)R(1) (1L3V) was enhanced by ERp44 C160S/C212S mutation. Taken together, these results suggest that the mutants of ERp44, C160/C212, can more tightly bind to IP(3)R(1) but exhibit a weak inhibition of IP(3)R(1) channel activity in Hela cells.
Adenosine Triphosphate
;
pharmacology
;
Amino Acid Substitution
;
Biological Transport
;
drug effects
;
physiology
;
Blotting, Western
;
Calcium
;
metabolism
;
Calcium Signaling
;
drug effects
;
physiology
;
HeLa Cells
;
Humans
;
Immunoprecipitation
;
Inositol 1,4,5-Trisphosphate
;
metabolism
;
Inositol 1,4,5-Trisphosphate Receptors
;
physiology
;
Membrane Potentials
;
drug effects
;
physiology
;
Membrane Proteins
;
genetics
;
metabolism
;
Microscopy, Confocal
;
Molecular Chaperones
;
genetics
;
metabolism
;
Mutation
;
Plasmids
;
Transfection
2.Structural insight into enhanced calcium indicator GCaMP3 and GCaMPJ to promote further improvement.
Yingxiao CHEN ; Xianqiang SONG ; Sheng YE ; Lin MIAO ; Yun ZHU ; Rong-Guang ZHANG ; Guangju JI
Protein & Cell 2013;4(4):299-309
Genetically encoded Ca(2+) indicators (GECI) are important for the measurement of Ca(2+) in vivo. GCaMP2, a widely-used GECI, has recently been iteratively improved. Among the improved variants, GCaMP3 exhibits significantly better fluorescent intensity. In this study, we developed a new GECI called GCaMPJ and determined the crystal structures of GCaMP3 and GCaMPJ. GCaMPJ has a 1.5-fold increase in fluorescence and 1.3-fold increase in calcium affinity over GCaMP3. Upon Ca(2+) binding, GCaMP3 exhibits both monomeric and dimeric forms. The structural superposition of these two forms reveals the role of Arg-376 in improving monomer performance. However, GCaMPJ seldom forms dimers under conditions similar to GCaMP3. St ructural and mutagenesis studies on Tyr-380 confirmed its importance in blocking the cpEGFP β-barrel holes. Our study proposes an efficient tool for mapping Ca(2+) signals in intact organs to facilitate the further improvement of GCaMP sensors.
Calcium
;
chemistry
;
metabolism
;
Calmodulin
;
chemistry
;
genetics
;
metabolism
;
Crystallography, X-Ray
;
Dimerization
;
Green Fluorescent Proteins
;
chemistry
;
genetics
;
metabolism
;
Histidine
;
chemistry
;
genetics
;
metabolism
;
Hydrogen-Ion Concentration
;
Myosin-Light-Chain Kinase
;
chemistry
;
genetics
;
metabolism
;
Peptide Fragments
;
chemistry
;
genetics
;
metabolism
;
Protein Structure, Tertiary
;
Recombinant Fusion Proteins
;
biosynthesis
;
chemistry
;
genetics
3.Corneal confocal microscopy and its application in ischemic cerebrovascular disease
Jihong LIU ; Yingxiao JI ; Min CHEN ; Rui ZHAI ; Zhipeng CAI ; Litao LI
International Journal of Cerebrovascular Diseases 2022;30(8):605-610
Corneal confocal microscopy (CCM) is an in vivo corneal imaging technique, which can directly quantify corneal nerve fibers in real time. It has the characteristics of non-invasive, objective and high sensitivity. CCM can not only be used for the diagnosis and treatment evaluation of corneal diseases, but also plays an important role in the diagnosis and prognosis evaluation of some peripheral and central nervous system diseases, such as diabetes peripheral neuropathy and Parkinson's disease. In addition, the changes of corneal nerve fibers can indirectly reflect the severity of ischemic cerebrovascular disease, and it is expected to become a noninvasive bioimaging marker of ischemic cerebrovascular disease. This article reviews CCM and its application in ischemic cerebrovascular disease, in order to provide better means for early diagnosis and prognosis evaluation of ischemic cerebrovascular disease.
4.Research advances on the regulation of microglia polarization by autophagy in ischemic stroke
Fangming WANG ; Wenxuan SHANG ; Jingwen ZHANG ; Yingxiao JI ; Litao LI
The Journal of Practical Medicine 2024;40(9):1324-1330
Ischemic stroke is feature by high incidence,high disability and high mortality.Inflammation plays an important role in the occurrence and development of ischemic stroke.Activated microglia exhibit two different phenotypes of proinflammatory(M1)and anti-inflammatory(M2),and regulating the transformation of microglia from M1 to M2 is the key to clinical benefit.Recent studies have shown that autophagy plays a key role in regulating phenotypic transformation of microglia.How to exert the regulatory role of autophagy and promote the transformation of microglia into M2 type has become a hotspot of clinical research in reducing secondary brain injury after stroke.This paper reviews the research progress of autophagy regulation of microglia polarization in ischemic stroke,aim-ing to provide a reference for further clinical and basic research in this field.
5.Recent advance in corneal confocal microscopy for neurological diseases
Jihong LIU ; Yingxiao JI ; Rui ZHAI ; Min CHEN ; Zhipeng CAI ; Litao LI
Chinese Journal of Neuromedicine 2023;22(1):97-100
Corneal confocal microscopy (CCM) is a non-invasive, simple and rapid visual corneal imaging technique, which can directly conduct real-time collection and quantitative analysis of corneal nerve fibers. Studies have shown that CCM can be used in the diagnosis and prognosis evaluation of degenerative diseases, demyelinating diseases, degenerative diseases and other types of diseases of the central nervous system. In this paper, the recent advance in CCM in neurological diseases is summarized to provide new ideas for their diagnosis and prognosis evaluation.